Obesity Compound Library
Catalog No.L6700
Offered in 96 or 384 well plate format

A unique collection of 936 compounds used for research in obesity.
Selleck Chemicals compound library contributes and expedites
the investigation of treatments against COVID19
The researchers at the National Institute of Infectious Diseases, in Japan, successfully found anti-COVID19 drugs within 3 months of
screening FDA-approved drug library from Selleck Chemicals. They have already published this article doi: 10.1101/2020.04.14.039925.
You Could Select:
Obesity Compound Library Contents
Description & Advantages
•Obesity is a leading preventable cause of death worldwide, with increasing rates in adults and children. Obesity is a new direction worth exploring which increases the likelihood of various diseases and conditions, particularly cardiovascular diseases,type 2 diabetes,obstructive sleep apnea, certain types of cancer,osteoarthritis, and depression
•A unique collection of 936 obesity related compounds for high throughput screening (HTS) and high content screening (HCS)
•Covers multiple pathways:JAK/STAT,IGF,PI3K/Akt/mTOR,FAAH,MAPK,etc.
•Some compounds have been approved by the FDA
•Structurally diverse,medicinally active,and cell permeable
•Rich documentation with structure and bioactivity information
•NMR and HPLC validated to ensure high purity
Product Details
Formulation: | 882 compounds pre-dissolved in 10mM DMSO, 23 compounds pre-dissolved in 10mM water and 31 compounds pre-dissolved in 2mM DMSO |
---|---|
Container: | 96 Well Format Sample Storage Tube With Screw Cap and Optional 2D Barcode |
Stability: | in DMSO |
in DMSO | |
Shipping: | Blue ice or dry ice |